ArticleScientific reports2017

Inhibition of Wnt/β-Catenin pathway and Histone acetyltransferase activity by Rimonabant: a therapeutic target for colon cancer.

Maria Chiara Proto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.